Ishikawa N, Eguchi K, Otsubo T, Ueki Y, Fukuda T, Tezuka H, Matsunaga M, Kawabe Y, Shimomura C, Izumi M
J Clin Endocrinol Metab. 1987 Jul;65(1):17-23. doi: 10.1210/jcem-65-1-17.
The expression of surface markers associated with activation and characterization was compared among T cells in thyroid glands and peripheral blood of 10 patients with Graves' hyperthyroidism receiving chronic antithyroid drug therapy, in peripheral blood of 15 patients with untreated hyperthyroid Graves' disease, and in peripheral blood of 21 normal subjects using two-color flow cytometry. In the chronically treated Graves' disease patients, the percentage of activated T cells (HLA-DR+ T cells) among total T cells was significantly higher in thyroid tissue than in peripheral blood, and the increase in percent activated T cells was also significant among both helper/inducer T cell (CD4+ cell) and suppressor/cytotoxic T cell (CD8+ cell) subsets. The percentage of activated T cells in peripheral blood was not significantly different between chronically treated hyperthyroid Graves' patients and normal subjects, whereas the percentage of activated T cells in the peripheral blood from untreated hyperthyroid Graves' disease patients was significantly higher than that in normal subjects or chronically treated hyperthyroid Graves' patients. The percentages of CD4+ cells and CD8+ cells among total T cells were not different between thyroid tissues and peripheral blood in patients with chronically treated hyperthyroid Graves' disease. When CD4+ were further divided into helper T cells (CD4+2H4- cells) and suppressor-inducer T cells (CD4+2H4+ cells) using two-color flow cytometry, the percentage of helper T cells among CD4+ cells was significantly higher in thyroid tissue than in peripheral blood, resulting in an increased ratio of CD4+2H4- cells to CD4+2H4+ cells. The percentage of CD4+2H4+ cells in peripheral blood, however, was not significantly different among untreated and chronically treated Graves' disease patients and normal subjects. From the findings of abnormalities in intrathyroidal T cell subsets, we suggest that the decrease in the function of suppressor T cells within the thyroids of Graves' disease patients may be due to a decrease in CD4+2H4+ cells within thyroid tissue.
采用双色流式细胞术,比较了10例接受慢性抗甲状腺药物治疗的Graves病甲亢患者甲状腺和外周血中的T细胞、15例未经治疗的甲亢Graves病患者外周血中的T细胞以及21例正常受试者外周血中与激活和特征相关的表面标志物的表达。在接受慢性治疗的Graves病患者中,甲状腺组织中总T细胞中活化T细胞(HLA-DR+ T细胞)的百分比显著高于外周血,并且在辅助/诱导性T细胞(CD4+细胞)和抑制/细胞毒性T细胞(CD8+细胞)亚群中,活化T细胞百分比的增加也很显著。接受慢性治疗的甲亢Graves病患者外周血中活化T细胞的百分比与正常受试者之间无显著差异,而未经治疗的甲亢Graves病患者外周血中活化T细胞的百分比显著高于正常受试者或接受慢性治疗的甲亢Graves病患者。接受慢性治疗的甲亢Graves病患者甲状腺组织和外周血中总T细胞中CD4+细胞和CD8+细胞的百分比无差异。当使用双色流式细胞术将CD4+进一步分为辅助性T细胞(CD4+2H4-细胞)和抑制诱导性T细胞(CD4+2H4+细胞)时,甲状腺组织中CD4+细胞中辅助性T细胞的百分比显著高于外周血,导致CD4+2H4-细胞与CD4+2H4+细胞的比例增加。然而,未经治疗和接受慢性治疗的Graves病患者以及正常受试者外周血中CD4+2H4+细胞的百分比无显著差异。根据甲状腺内T细胞亚群异常的发现,我们认为Graves病患者甲状腺内抑制性T细胞功能的降低可能是由于甲状腺组织内CD4+2H4+细胞的减少。